基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
He's also been outspoken about the pharmaceutical industry's role in pushing what he calls the glucocentric agenda—“The data show that glucose control is not doing everything it says on the tin. So why this drive to push it by professional associations and guideline committees?”—and pre-diabetes—“What is pre-diabetes? Does it exist? If it does why is its definition being expanded way beyond the data points, and is the pressure behind trying to get people on treatment for pre-diabetes anything to do with the pharmaceutical industry?”
Research Interests
Papers共 281 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PLOS global public healthno. 5 (2024): e0003168-e0003168
Journal of Epidemiology and Global Healthpp.1-9, (2024)
Aida Abdraimova,Stéphane Besançon,Jill Portocarrero,Kaushik Ramaiya, Asel Dunganova,Margaret Ewen,Hans Hogerzeil,Maria Lazo-Porras,Richard Laing,Molly Lepeska, Happy Nchimbi,Assa Sidibé,
Amanda Adler,Peter Bennett, Stephen Colagiuri Chair,Edward Gregg,KM Venkat Narayan,Maria Inês Schmidt,Eugene Sobngwi,Naoko Tajima,Nikhil Tandon,Nigel Unwin,Sarah Wild,John Yudkin,
LANCET DIABETES & ENDOCRINOLOGYno. 12 (2021): 825-836
The Lancet Diabetes & Endocrinology (2021)
Load More
Author Statistics
#Papers: 284
#Citation: 54290
H-Index: 70
G-Index: 233
Sociability: 7
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn